{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:02:30Z","timestamp":1787583750967,"version":"build-2736575974"},"reference-count":114,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The pituitary gland is one of the most cellularly diverse regions of the brain. Recent advancements in transcriptomic biology, such as single-cell RNA sequencing, bring an unprecedented glimpse into the molecular composition of the pituitary, both in its normal physiological state and in disease. Deciphering the normal pituitary transcriptomic signatures provides a better insight into the ontological origin and development of five types of endocrine cells, a process involving complex cascades of transcription factors that are still being established. In parallel with these observations about normal pituitary development, recent transcriptomic findings on pituitary neuroendocrine tumors (PitNETs) demonstrate both preservations and changes in transcription factor expression patterns compared to those seen during gland development. Furthermore, recent studies also identify differentially expressed genes that drive various tumor behaviors, including hormone hypersecretion and tumor aggression. Understanding the comprehensive multiomic profiles of PitNETs is essential in developing molecular profile-based therapies for PitNETs not curable with current treatment modalities and could eventually help align PitNETs with the breakthroughs being made in applying precision medicine to other tumors.<\/jats:p>","DOI":"10.3390\/cancers15010110","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:50:01Z","timestamp":1672109401000},"page":"110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells"],"prefix":"10.3390","volume":"15","author":[{"given":"Jun Y.","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-2176","authenticated-orcid":false,"given":"Robert C.","family":"Osorio","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangham","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Carrete","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeki","family":"Lad","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of California San Francisco, San Francisco, CA 94143, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s12276-021-00597-9","article-title":"Neuroendocrine control of appetite and metabolism","volume":"53","author":"Yoo","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fendo.2015.00177","article-title":"Homeostatic Control of the Thyroid\u2013Pituitary Axis: Perspectives for Diagnosis and Treatment","volume":"6","author":"Hoermann","year":"2015","journal-title":"Front. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ncpendmet0159","article-title":"Mechanisms of disease: The pathogenesis of pituitary tumors","volume":"2","author":"Ezzat","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and Treatment of Pituitary Adenomas: A Review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/jc.2018-00688","article-title":"Clinical and Pathological Aspects of Silent Pituitary Adenomas","volume":"104","author":"Drummond","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","first-page":"15","article-title":"Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior","volume":"112","author":"Spada","year":"2022","journal-title":"NEN"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17446651.2022.2082942","article-title":"Recent advancements in the molecular biology of pituitary adenomas","volume":"17","author":"Zheng","year":"2022","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","article-title":"Tumour heterogeneity and metastasis at single-cell resolution","volume":"20","author":"Lawson","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-00990-4","article-title":"High-throughput single-cell sequencing in cancer research","volume":"7","author":"Jia","year":"2022","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1152\/physrev.00006.2006","article-title":"Molecular Physiology of Pituitary Development: Signaling and Transcriptional Networks","volume":"87","author":"Zhu","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(01)00282-3","article-title":"A Pituitary Cell-Restricted T Box Factor, Tpit, Activates POMC Transcription in Cooperation with Pitx Homeoproteins","volume":"104","author":"Lamolet","year":"2001","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1101\/gad.1065703","article-title":"Tpit determines alternate fates during pituitary cell differentiation","volume":"17","author":"Pulichino","year":"2003","journal-title":"Genes Dev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1038\/s41467-020-19012-4","article-title":"Single-cell transcriptomics identifies divergent developmental lineage trajectories during human pituitary development","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/JME-18-0090","article-title":"The proneural bHLH genes Mash1, Math3 and NeuroD are required for pituitary development","volume":"61","author":"Ando","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/me.2003-0127","article-title":"Tpit-Independent Function of NeuroD1(BETA2) in Pituitary Corticotroph Differentiation","volume":"18","author":"Lamolet","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"110467","DOI":"10.1016\/j.celrep.2022.110467","article-title":"Single nucleus transcriptome and chromatin accessibility of postmortem human pituitaries reveal diverse stem cell regulatory mechanisms","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"19968","DOI":"10.1016\/S0021-9258(17)32115-4","article-title":"A novel human homeobox gene distantly related to proboscipedia is expressed in lymphoid and pancreatic tissues","volume":"269","author":"Harrison","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0896-6273(01)80026-X","article-title":"Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity","volume":"23","author":"Arber","year":"1999","journal-title":"Neuron"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/endocrines1010006","article-title":"Recent Progress in Stem Cell Research of the Pituitary Gland and Pituitary Adenoma","volume":"1","author":"Toda","year":"2020","journal-title":"Endocrines"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1101\/gad.1444706","article-title":"Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis","volume":"20","author":"hu","year":"2006","journal-title":"Genes Dev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1210\/en.2016-1372","article-title":"Foxo1 Is Required for Normal Somatotrope Differentiation","volume":"157","author":"Kapali","year":"2016","journal-title":"Endocrinology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/me.2011-1075","article-title":"CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation","volume":"25","author":"Tong","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/s41467-021-22859-w","article-title":"Single nucleus multi-omics regulatory landscape of the murine pituitary","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1210\/en.2018-00750","article-title":"Single-Cell RNA Sequencing Reveals Novel Markers of Male Pituitary Stem Cells and Hormone-Producing Cell Types","volume":"159","author":"Cheung","year":"2018","journal-title":"Endocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Veldhuis, J.D., and Giustina, A. (1999). Somatotrope Heterogeneity and Its Involvement in Growth Hormone (GH) Regulation, Sex-Steroid Interactions with Growth Hormone.","DOI":"10.1007\/978-1-4612-1546-2"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1074\/jbc.275.5.3100","article-title":"The Pit-1 Homeodomain and \u03b2-Domain Interact with Ets-1 and Modulate Synergistic Activation of the Rat Prolactin Promoter *","volume":"275","author":"Bradford","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_28","first-page":"3965","article-title":"Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary","volume":"159","author":"Peel","year":"2018","journal-title":"Endocrinology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1038\/ncomms11121","article-title":"ZBTB20 is required for anterior pituitary development and lactotrope specification","volume":"7","author":"Cao","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"bqac181","DOI":"10.1210\/endocr\/bqac181","article-title":"ZBTB20 Regulates Prolactin Expression and Lactotrope Function in Adult Mice","volume":"163","author":"Han","year":"2022","journal-title":"Endocrinology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3389\/fendo.2019.00623","article-title":"Cell Type- and Sex-Dependent Transcriptome Profiles of Rat Anterior Pituitary Cells","volume":"10","author":"Fletcher","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuropharm.2008.06.022","article-title":"Role of metabotropic glutamate receptors in the control of neuroendocrine function","volume":"55","author":"Durand","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s13238-020-00705-x","article-title":"Single-cell transcriptomic analysis of adult mouse pituitary reveals sexual dimorphism and physiologic demand-induced cellular plasticity","volume":"11","author":"Ho","year":"2020","journal-title":"Protein Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80770-9","article-title":"Reciprocal Interactions of Pit1 and GATA2 Mediate Signaling Gradient\u2013Induced Determination of Pituitary Cell Types","volume":"97","author":"Dasen","year":"1999","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Daly, A.Z., Dudley, L.A., Peel, M.T., Liebhaber, S.A., Parker, S.C.J., and Camper, S.A. (2021). Multi-omic profiling of pituitary thyrotropic cells and progenitors. BMC Biol., 19.","DOI":"10.1186\/s12915-021-01009-0"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/me.2005-0378","article-title":"Pituitary-Specific Gata2 Knockout: Effects on Gonadotrope and Thyrotrope Function","volume":"20","author":"Charles","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/me.2015-1192","article-title":"ISL1 Is Necessary for Maximal Thyrotrope Response to Hypothyroidism","volume":"29","author":"Castinetti","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1242\/dev.128.2.147","article-title":"Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function","volume":"128","author":"Zhao","year":"2001","journal-title":"Development"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13072-019-0291-8","article-title":"Identification of a pituitary ER\u03b1-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor","volume":"12","author":"Pacini","year":"2019","journal-title":"Epigenetics Chromatin"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3803\/EnM.2013.28.4.245","article-title":"The molecular pathogenesis of pituitary adenomas: An update","volume":"28","author":"Jiang","year":"2013","journal-title":"Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO Classification of Pituitary Tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"M73","DOI":"10.1530\/EJE-15-0320","article-title":"Decoding the genetic basis of Cushing\u2019s disease: USP8 in the spotlight","volume":"173","author":"Theodoropoulou","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"16","author":"Mizuno","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1128\/MCB.01566-06","article-title":"Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo","volume":"27","author":"Niendorf","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J. Clin. Invest."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1038\/s41467-018-05275-5","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","article-title":"Driver mutations in USP8 wild-type Cushing\u2019s disease","volume":"21","author":"Sbiera","year":"2019","journal-title":"Neuro-Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"123\u2013134.e5","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic Classification of Pituitary Neuroendocrine Tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/neuonc\/noab102","article-title":"Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors","volume":"23","author":"Cui","year":"2021","journal-title":"Neuro-Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","article-title":"Lineage tracing meets single-cell omics: Opportunities and challenges","volume":"21","author":"Wagner","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fendo.2017.00055","article-title":"Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas","volume":"8","author":"Lerario","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix MetalloProteinases (MMPs) andTissue Inhibitors of MetalloProteinases (TIMPs): Positive and negative regulators intumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/MCB.20.3.1044-1054.2000","article-title":"Death-Associated Protein Kinase-Related Protein 1, a Novel Serine\/Threonine Kinase Involved in Apoptosis","volume":"20","author":"Inbal","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s40618-015-0298-3","article-title":"Telomere length and telomerase expression in pituitary tumors","volume":"38","author":"Martins","year":"2015","journal-title":"J. Endocrinol. Invest."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12022-021-09702-0","article-title":"Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors","volume":"33","author":"Alzoubi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_60","first-page":"1934","article-title":"Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling","volume":"52","author":"Ren","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wu, Q., Yin, X., Zhao, W., Xu, W., and Chen, L. (2021). Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt\/\u03b2-catenin signaling. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260864"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-21-1183","article-title":"Single Cell RNA Sequencing in Silent Corticotroph Tumors Confirms Impaired POMC Processing and Provides New Insights into Their Invasive Behavior","volume":"187","author":"Zhang","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Eieland, A.K., Normann, K.R., Sundaram, A.Y.M., Nyman, T.A., \u00d8ystese, K.A.B., Lekva, T., Berg, J.P., Bollerslev, J., and Olarescu, N.C. (2020). Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas. Cancers, 12.","DOI":"10.3390\/cancers12102980"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"111223","DOI":"10.1016\/j.celrep.2022.111223","article-title":"Pituitary adenomas evade apoptosis via noxa deregulation in Cushing\u2019s disease","volume":"40","author":"Asuzu","year":"2022","journal-title":"Cell Reports"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/jcem-71-6-1421","article-title":"Clinical, Biochemical, and Morphological Correlates in Patients Bearing Growth Hormone-Secreting Pituitary Tumors with or without Constitutively Active Adenylyl Cyclase","volume":"71","author":"SPADA","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1009917920589","article-title":"Molecular Pathogenesis of Acromegaly","volume":"2","author":"Drange","year":"1999","journal-title":"Pituitary"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","article-title":"Minireview: GNAS: Normal and Abnormal Functions","volume":"145","author":"Weinstein","year":"2004","journal-title":"Endocrinology"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Yamamoto, M., and Takahashi, Y. (2022). Genetic and Epigenetic Pathogenesis of Acromegaly. Cancers, 14.","DOI":"10.3390\/cancers14163861"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11102-015-0662-5","article-title":"Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: A meta-analysis","volume":"18","author":"Efstathiadou","year":"2015","journal-title":"Pituitary"},{"key":"ref_71","first-page":"1604","article-title":"Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas","volume":"83","author":"Barlier","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_72","first-page":"2077","article-title":"Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies","volume":"80","author":"Adams","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing\u2019s Disease and Endocrine-Inactive Subtypes","volume":"24","author":"Salomon","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2213-8587(14)70169-X","article-title":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): A randomised, phase 3 trial","volume":"2","author":"Gadelha","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1126\/science.288.5463.154","article-title":"Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity","volume":"288","author":"Rocheville","year":"2000","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-016-0778-2","article-title":"Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas","volume":"20","author":"Liu","year":"2017","journal-title":"Pituitary"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1530\/eje.1.02348","article-title":"Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours","volume":"156","author":"Colao","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cantone, M.C., Dicitore, A., and Vitale, G. (2021). Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030501"},{"key":"ref_79","first-page":"731\u2013744.e9","article-title":"Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene","volume":"68","author":"Hasson","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","article-title":"Somatic SF3B1 hotspot mutation in prolactinomas","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts","volume":"365","author":"apaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41467-020-15171-6","article-title":"Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns","volume":"11","author":"Tang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-020-00220-5","article-title":"The biological function and clinical significance of SF3B1 mutations in cancer","volume":"8","author":"Zhou","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-022-02245-0","article-title":"The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1","volume":"41","author":"Guo","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0896-6273(00)80352-9","article-title":"Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia","volume":"19","author":"Saiardi","year":"1997","journal-title":"Neuron"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/endo.140.11.7118","article-title":"Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice","volume":"140","author":"Asa","year":"1999","journal-title":"Endocrinology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0896-6273(00)80353-0","article-title":"Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter","volume":"19","author":"Fumagalli","year":"1997","journal-title":"Neuron"},{"key":"ref_89","first-page":"568","article-title":"Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors","volume":"78","author":"Friedman","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Biagetti, B., and Sim\u00f2, R. (2021). Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011247"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000126764","article-title":"Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas","volume":"60","author":"Caccavelli","year":"1994","journal-title":"Neuroendocrinology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11060-009-0107-y","article-title":"Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: Correlation with the response to bromocriptine and with tumor biological behavior","volume":"99","author":"Wu","year":"2010","journal-title":"J. Neurooncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2826.1996.04902.x","article-title":"Alteration of G\u03b1 Subunits mRNA Levels in Bromocriptine Resistant Prolactinomas","volume":"8","author":"Caccavelli","year":"1996","journal-title":"J. Neuroendocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jcem-69-3-500","article-title":"Resistance to Bromocriptine in Prolactinomas","volume":"69","author":"Pellegrini","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_95","first-page":"163","article-title":"Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists","volume":"89","author":"Passos","year":"2009","journal-title":"NEN"},{"key":"ref_96","first-page":"353","article-title":"Nerve Growth Factor Regulates Dopamine D2 Receptor Expression in Prolactinoma Cell Lines via p75NGFR-Mediated Activation of Nuclear Factor-\u03baB","volume":"16","author":"Iorentini","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1073\/pnas.90.17.7961","article-title":"Nerve growth factor suppresses the transforming phenotype of human prolactinomas","volume":"90","author":"Missale","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1677\/ERC-07-0062","article-title":"A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors","volume":"14","author":"Wierinckx","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","article-title":"Prognostic factors in prolactin pituitary tumors: Clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up","volume":"95","author":"Raverot","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/mend.13.1.0225","article-title":"Structure, Expression, and Function of Human Pituitary Tumor-Transforming Gene (PTTG)","volume":"13","author":"Zhang","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Fong, M.Y., Farghaly, H., and Kakar, S.S. (2012). Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivoinvestigated using a transgenic mouse model, and effects of cross breeding with p53 (+\/\u2212) transgenic mice. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-532"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/15275","article-title":"Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis","volume":"5","author":"Heaney","year":"1999","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng1060","article-title":"A molecular signature of metastasis in primary solid tumors","volume":"33","author":"Ramaswamy","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1023511","DOI":"10.3389\/fmolb.2022.1023511","article-title":"ADAMTS6: Emerging roles in cardiovascular, musculoskeletal and cancer biology","volume":"9","author":"Mead","year":"2022","journal-title":"Front Mol. Biosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/jc.2016-2261","article-title":"Whole-Exome Sequencing Study of Thyrotropin-Secreting Pituitary Adenomas","volume":"102","author":"Sapkota","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_106","first-page":"1134","article-title":"Screening of candidate oncogenes in human thyrotroph tumors: Absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes","volume":"81","author":"Dong","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_107","first-page":"5572","article-title":"Somatic Mutation of TR\u03b2 Can Cause a Defect in Negative Regulation of TSH in a TSH-Secreting Pituitary Tumor","volume":"86","author":"Ando","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"E948","DOI":"10.1210\/jc.2010-2496","article-title":"Aberrant Expression of Thyroid Hormone Receptor \u03b2 Isoform May Cause Inappropriate Secretion of TSH in a TSH-Secreting Pituitary Adenoma","volume":"96","author":"Tagami","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","article-title":"Null cell adenomas of the pituitary gland: An institutional review of their clinical imaging and behavioral characteristics","volume":"26","author":"Balogun","year":"2015","journal-title":"Endocr. Pathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2020.3.FOCUS20114","article-title":"Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution","volume":"48","author":"Haddad","year":"2020","journal-title":"Neurosurg. Focus"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/ERC-10-0018","article-title":"Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis","volume":"17","author":"Galland","year":"2010","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/bjc.2017.352","article-title":"Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence","volume":"117","author":"Letellier","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.24641","article-title":"Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis","volume":"126","author":"an","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"983793","DOI":"10.3389\/fendo.2022.983793","article-title":"Biological effects and regulation of IGFBP5 in breast cancer","volume":"13","author":"Dittmer","year":"2022","journal-title":"Front. Endocrinol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/1\/110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:50:18Z","timestamp":1760147418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/1\/110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cancers15010110"],"URL":"https:\/\/doi.org\/10.3390\/cancers15010110","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]}}}